Daniel Polhamus

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus

Jorge Luiz Gross, James A. Rogers, Daniel Polhamus et al. · BMJ Open · 2013 · 34 citations · Full text

Exposure–response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane

Chunze Li, Bei Wang, Shang‐Chiung Chen et al. · Cancer Chemotherapy and Pharmacology · 2017 · 28 citations

Breast Oncology, Medicine, Pathology +7

Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia

Gerald R. Galluppi, Daniel Polhamus, Jeannine M. Fisher et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 25 citations · Full text

Population pharmacokinetics and exposure–response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2‐targeted regimens

S Chen, Angelica Quartino, Daniel Polhamus et al. · British Journal of Clinical Pharmacology · 2017 · 19 citations · Full text

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

Ophelia Yin, Hamim Zahir, Jonathan French et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 10 citations · Full text